Express News | JPMorgan: Downgraded the Target Price for Vertex Pharmaceuticals from $503 to $500, but maintained the 'Shareholding' rating.

Breakings14:36

Jim Cramer on Vertex Pharmaceuticals Incporated (VRTX): 'This Is Hardly Down For The Year. I Think It Can Still Go Lower'

Yahoo FinanceDec 25 20:51

Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Vertex Pharmaceuticals (VRTX)

TipRanksDec 25 20:01 · Ratings

Truist Financial Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $460

Futu NewsDec 25 19:32 · Ratings

Will Vertex Pharmaceuticals Incorporated (VRTX) Make You Rich In 2025?

Yahoo FinanceDec 25 12:02

Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know

Yahoo FinanceDec 25 06:50